BiondVax To Receive €500,000 Grant From EU

Israeli company BiondVax, which is developing a universal influenza vaccine, is one of six companies to receive the prestigious Seventh Framework Program for Research (FP7) award. The six companies will receive a total of €6 million, €500,000 of which will be granted to BiondVax.